Ovarian Cancer

The Pharmacy Times® Ovarian Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to the group of diseases that originates in the ovaries, fallopian tubes, or the peritoneum.

Latest News

Teal ribbon for ovarian cancer awareness -- Image credit: Queenmoonlite Studio | stock.adobe.com
FDA Approves Avutometinib/Defactinib for Adults With KRAS-Mutated Recurrent LGSOC

May 8th 2025

With the FDA approval, avutometinib/defactinib is now the first and only FDA-approved treatment for patients with recurrent low-grade serous ovarian cancer (LGSOC).

Ovarian cancer -- Image credit: Dr_Microbe | stock.adobe.com
INX-315 Granted FDA Fast Track Designation for Platinum-Resistant/Refractory Ovarian Cancer

May 5th 2025

Ovarian cancer -- Image credit: Lars Neumann | stock.adobe.com
CUSP06 Granted FDA Fast Track Designation for Patients With Platinum-Resistant Ovarian Cancer

February 13th 2025

Ovarian cancer, 3D illustration - Image credit: Dr_Microbe | stock.adobe.com
Avutometinib Plus Defactinib Moves One Step Closer to Approval for Treatment of Ovarian Cancer

January 6th 2025

Teal ribbon for ovarian cancer awareness -- Image credit: Queenmoonlite Studio | stock.adobe.com
Avutometinib With Defactinib for Recurrent KRAS Mutant LGSOC Completes Rolling New Drug Application

November 2nd 2024

<12345
OSZAR »